Notice of Application - 2010
FR Doc 2010-21747[Federal Register: September 1, 2010 (Volume 75, Number 169)]
[Notices]
[Page 53719]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01se10-92]
[[Page 53719]]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in Schedule I or II, and prior to issuing a
regulation under 21 U.S.C. 952(a) (2) authorizing the importation of
such a substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Title 21 of the Code of Federal
Regulations Sec. 1301.34(a), this is notice that on May 5, 2010,
AllTech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as an importer of the basic classes of
controlled substances listed in schedule I and II:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Heroin (9200) |
I |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Hydrocodone (9193) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
The company plans to import these controlled substances for the
manufacture of reference standards.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic class of controlled
substance may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43 and in
such form as prescribed by 21 CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than October 1, 2010.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled
substance in schedule I or II are, and will continue to be, required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and
21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: August 3, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-21747 Filed 8-31-10; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |